Mutation analysis in Saudi Duchenne and Becker muscular dystrophy patients using multiplex PCR

Archives of Medical Science

Volumn 4, Issue 1, 2008, Pages 16-21

  Chaudhary, Adeel G ^a   Alqahtani, Mohammed H ^a   Abuzenadah, Adel ^a   Gari, Mamdooh ^a   Al Sofyani, Abeer A ^a   Al Aama, Jumana Y ^b   Lary, Sahira A ^a   Elaimi, Aisha H ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^b KING ABDUL AZIZ UNIVERSITY HOSPITAL   (Saudi Arabia)

Author keywords

BMD; Deletions; DMD gene; Dystrophin; Multiplex PCR; Saudi DMD

Indexed keywords

DYSTROPHIN;

ADOLESCENT; ADULT; ARTICLE; BECKER MUSCULAR DYSTROPHY; CLINICAL ARTICLE; CONTROLLED STUDY; DUCHENNE MUSCULAR DYSTROPHY; EXON; GENE AMPLIFICATION; GENE DELETION; GENE MUTATION; GENETIC ANALYSIS; HUMAN; MALE; MULTIPLEX POLYMERASE CHAIN REACTION; MUTAGENESIS; MUTATION RATE; MUTATIONAL ANALYSIS; SAUDI ARABIA;

EID: 42549144087     PISSN: 17341922     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Emery AE. The muscular dystrophies. Lancet 2002; 359: 687-95.
2. Stockley TL, Akber S, Bulgin N, Ray PN. Strategy for comprehensive molecular testing for Duchenne and Becker muscular dystrophies. Genet Test 2006; 10: 229-43.
3. Ahn AH, Kunkel LM. The structural and functional diversity of dystrophin. Nature Genet 1993; 3: 283-91.
4. Monaco AP, Bertelson CJ, Liechti-Gallati S, Moser H, Kunkel LM. An explanation for the phenotypic differences between patients bearing partial deletions of the DMD locus. Genomics 1988; 2: 90-5.
5. Aartsma-Rus A, van Deutekom JC, Fokkema IF, van Ommen GJ, Den Dunnen JT. Entries in the Leiden Duchenne muscular dystrophy mutation database: an overview of mutation types and paradoxical cases that confirm the reading-frame rule. Muscle Nerve 2006; 34: 135-44.
6. Blake DJ, Weir A, Newey SE, Davies KE. Function and genetics of dystrophin and dystrophin-related proteins in muscle. Physiol Rev 2002; 82: 291-329.
7. th ed. Nussbaum RL, McInnes RR, Willard HF (eds). W.B. Saunders, Philadelphia 2001; 225-9.
8. Muntoni F, Torelli S, Ferlini A. Dystrophin and mutations: one gene, several proteins, multiple phenotypes. Lancet Neurol 2003; 2: 731-40.
9. Beggs AH, Koenig M, Boyce FM, Kunkel LM. Detection of 98% of DMD/BMD gene deletions by polymerase chain reaction. Hum Genet 1990; 86: 45-8.
10. Hajdur LV, Kalia SK Dystrophinopathies and Nondystrophinopathies: from Molecular Biology to Clinical Diagnosis. University of Toronto Medical Journal 2000; 78: 14-20.
11. Al-Jumah M, Majumdar R, Al-Rajeh S, et al. Deletion mutations in the dystrophin gene of Saudi patients with Duchenne and Becker muscular dystrophy. Saudi Medical Journal 2002; 23: 1478-82.
12. Haider MJ, Bastaki L, Habib Y, Moosa A. Screening 25 dystrophin gene exons for deletions in Arab children with Duchenne muscular mystrophy. Human Heredit 1998; 48: 61-6.
13. Shrimpton AE, Thomson LL, Hoo JJ. Duchenne muscular dystrophy as a contiguous gene syndrome: del (X)(p21.2p21.3) with absence of dystrophin but normal multiplex PCR. Int Pediatr 2001; 16: 168-72.
14. Lenk U, Hanke R, Thiele H, Speer A. Point mutations at the carboxy terminus of the human dystrophin gene: implications for an association with mental retardation in DMD patients. Hum Mol Genet 1993; 2: 1877-81.
15. Roberts RG, Gardner RJ, Bobrow M. Searching for the 1 in 2,400,000: a review of dystrophin gene point mutations. Hum Mutat 1994; 4: 1-11.
16. Slater HR, Bruno DL, Ren H, Pertile M, Schouten JP, Choo KH. Rapid, high throughput prenatal detection of aneuploidy using a novel quantitative method (MLPA). J Med Genet 2003; 40: 907-12.
17. Lai KK, Lo IF, Tong TM, Cheng LY, Lam ST. Detecting exon deletions and duplications of the DMD gene using multiplex ligation-dependent probe amplification (MLPA). Clin Biochem 2006; 39: 367-72.
18. Basak J, Dasgupta UB, Banerjee TK, Senapati AK, Das SK, Mukherjee SC. Analysis of dystrophin gene deletions by multiplex PCR in eastern India. Neurol India 2006; 54: 310.
19. Kamolsilp M, Paditaporn R, Noonai A, Wasant P. Detection of DMD gene deletions in Thai children patients. Southeast Asian J Trop Med Public Health 1995; 26: 172-4.
20. Mutirangura A, Norapucsunton T, Srivuthana S, et al. Multiplex PCR to detect the dystrophin gene deletion in Thai patients. J Med Assoc Thai 1995; 78: 460-5.
21. Florentin L, Mavrou A, Kekou K, Metaxotou C. Deletion patterns of Duchenne and Becker muscular dystrophies in Greece. J Med Genet 1995; 32: 48-51.
22. Kuseyri GN, Topalogulu H, Yuksel-Apak M, Kirdar B. Screening of deletions and RFLP analysis in Turkish DMD/BMD families by PCR. Clin Genet 1993; 43: 261-6.
23. Elhawary NA, Shawky RM, Hashem N. Frameshift deletion mechanisms in Egyptian Duchenne and Becker muscular dystrophy families. Molec Cells 2004; 18: 141-9.
24. Lo IF, Lai KK, Tong TM, Lam S. A different spectrum of DMD gene mutations in local Chinese patients with Duchenne/Becker muscular dystrophy. Chin Med J 2006; 119: 1079-87.
25. Hoogerwaard EM, Ginjaar IB, Bakker E, de Visser M. Dystrophin analysis in carriers of Duchenne and Becker muscular dystrophy. Neurology 2005; 65: 1984-6.
26. van Ommen GJ, Scheuerbrandt G. Workshop Report: Neonatal screening for muscular dystrophy. Neuromusc Disord 1993; 3: 231-9.